Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
- PMID: 23287624
- DOI: 10.1182/blood-2012-07-444851
Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
Abstract
High-dose cytarabine applied during remission induction or as consolidation after attainment of a complete remission has become an established element in the treatment of adults with acute myeloid leukemia. Recent evidence has challenged the need for these exceptionally high-dose levels of cytarabine. In this review, we present a reappraisal of the usefulness of high-dose cytarabine for acute myeloid leukemia treatment.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical